Evaluation of the clinical cutoff level of serum (1 → 3)-β-d-glucan in patients with connective tissue diseases complicated by deep fungal infections

Kenichi Kato, Satoru Onoda, Junichiro Asano, Shusaku Fukaya, Shunji Yoshida

研究成果: Article査読

3 被引用数 (Scopus)

抄録

Serum (1 → 3)-β-D-glucan levels and clinical findings were evaluated in 229 inpatients with connective tissue diseases (CTDs) during the period between June and October 2004. The mean serum (1 → 3)-β-D-glucan level was 129.7 ± 207.6 pg/mL in patients with a definitive diagnosis of fungal infections and 10.5 ± 8.6 pg/mL in patients without fungal infections. Analysis of the diagnostic sensitivity/specificity for various (1 → 3)-β-D-glucan cutoff levels gave the best results for a cutoff level of 15 pg/mL, with a sensitivity of 92.3% and specificity of 81.3%. This level was therefore determined to be the optimal cutoff in patients with CTDs.

本文言語English
ページ(範囲)366-369
ページ数4
ジャーナルModern Rheumatology
20
4
DOI
出版ステータスPublished - 08-01-2010

All Science Journal Classification (ASJC) codes

  • Rheumatology

フィンガープリント 「Evaluation of the clinical cutoff level of serum (1 → 3)-β-d-glucan in patients with connective tissue diseases complicated by deep fungal infections」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル